Patient participation in medical decision-making:: A French study in adjuvant radio-chemotherapy for early breast cancer

被引:45
作者
Protière, C
Viens, P
Genre, D
Cowen, D
Camerlo, J
Gravis, G
Alzieu, C
Bertucci, F
Resbeut, M
Maraninchi, D
Moatti, JP
机构
[1] Inst J Paoli I Calmettes, INSERM, U379, F-13273 Marseille 9, France
[2] Inst J Paoli I Calmettes, Reg Ctr Canc Care, F-13273 Marseille 9, France
[3] Univ Mediterranean, Marseille, France
关键词
breast cancer; choice; decision-making process; patient-physician relationship;
D O I
10.1023/A:1008390027720
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background: Shared decision-making is increasingly advocated as an ideal model. However, very few studies have tested the feasibility of giving patients the opportunity to participate in the choice of treatment. Patients and methods: Women, with non-metastatic breast cancer, eligible for non-intensified adjuvant chemotherapy attending our hospital were proposed two administrations of chemotherapy and radiotherapy: a sequential and a concomitant one. Two patient-questionnaires were used to elicit motivations for their choice and their degree of comfort with the process of decision-making and one questionnaire to test physicians' ability to predict patients' choice. Results: Participation rate in the study was 75.3% (n = 64). Majority (64%) of patients chose the concomitant treatment. Multivariate analysis revealed that patients with a lower level of education, who discussed the choice with social circle, and who most feared side-effects were more likely to choose the sequential treatment. Physicians were able to predict patients' choice in 66% of cases. 89% of patients declared that they were "fully satisfied" with having participated in the choice of treatment and 79% supported shared decision-making. Conclusions: Results are in favour of promoting active participation of cancer-patients in medical decision-making. The adequate degree of such participation remains however to be elicited and tested for therapeutic choices implying more difficult trade-offs between quantity and quality of life.
引用
收藏
页码:39 / 45
页数:7
相关论文
共 49 条
[1]   THE EUROPEAN-ORGANIZATION-FOR-RESEARCH-AND-TREATMENT-OF-CANCER QLQ-C30 - A QUALITY-OF-LIFE INSTRUMENT FOR USE IN INTERNATIONAL CLINICAL-TRIALS IN ONCOLOGY [J].
AARONSON, NK ;
AHMEDZAI, S ;
BERGMAN, B ;
BULLINGER, M ;
CULL, A ;
DUEZ, NJ ;
FILIBERTI, A ;
FLECHTNER, H ;
FLEISHMAN, SB ;
DEHAES, JCJM ;
KAASA, S ;
KLEE, M ;
OSOBA, D ;
RAZAVI, D ;
ROFE, PB ;
SCHRAUB, S ;
SNEEUW, K ;
SULLIVAN, M ;
TAKEDA, F .
JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1993, 85 (05) :365-376
[2]  
[Anonymous], 1993, WORLDS ILLNESS BIOGR
[3]  
ARROW KJ, 1963, AM ECON REV, V53, P941
[4]  
ASHCROFT J, 1984, BPOS P, P7
[5]   Quality of life assessment in patients receiving adjuvant therapy for breast cancer: The IBCSG approach [J].
Bernhard, J ;
Hurny, C ;
Coates, AS ;
Peterson, HF ;
CastiglioneGertsch, M ;
Gelber, RD ;
Goldhirsch, A ;
Senn, HJ ;
Rudenstam, CM .
ANNALS OF ONCOLOGY, 1997, 8 (09) :825-835
[6]   WHEN COMPETENT PATIENTS MAKE IRRATIONAL CHOICES [J].
BROCK, DW ;
WARTMAN, SA .
NEW ENGLAND JOURNAL OF MEDICINE, 1990, 322 (22) :1595-1599
[7]   THE PATIENTS ROLE IN CLINICAL DECISION-MAKING [J].
BRODY, DS .
ANNALS OF INTERNAL MEDICINE, 1980, 93 (05) :718-722
[8]   PATIENTS CHOICE OF TREATMENT IN STAGE-D PROSTATE-CANCER [J].
CASSILETH, BR ;
SOLOWAY, MS ;
VOGELZANG, NJ ;
SCHELLHAMMER, PS ;
SEIDMON, EJ ;
HAIT, HI ;
KENNEALEY, GT .
UROLOGY, 1989, 33 (05) :57-62
[9]   INFORMATION AND PARTICIPATION PREFERENCES AMONG CANCER-PATIENTS [J].
CASSILETH, BR ;
ZUPKIS, RV ;
SUTTONSMITH, K ;
MARCH, V .
ANNALS OF INTERNAL MEDICINE, 1980, 92 (06) :832-836
[10]   IMPROVING THE QUALITY-OF-LIFE DURING CHEMOTHERAPY FOR ADVANCED BREAST-CANCER - A COMPARISON OF INTERMITTENT AND CONTINUOUS TREATMENT STRATEGIES [J].
COATES, A ;
GEBSKI, V ;
BISHOP, JF ;
JEAL, PN ;
WOODS, RL ;
SNYDER, R ;
TATTERSALL, MHN ;
BYRNE, M ;
HARVEY, V ;
GILL, G ;
SIMPSON, J ;
DRUMMOND, R ;
BROWNE, J ;
VANCOOTEN, R ;
FORBES, JF .
NEW ENGLAND JOURNAL OF MEDICINE, 1987, 317 (24) :1490-1495